Scopolamine butylbromide

Overview

Scopolamine butylbromide (Hyoscine butylbromide) is an orally active anticholinergic agent and spasmolytic. Scopolamine butylbromide binds with high affinity to rat cardiac M2 ( K i 83 nmol/L), hM2 ( K i 233 nmol/L), rat intestinal M3 ( K i 290 nmol/L) and hM3 ( K i 643 nmol/L) muscarinic receptors. Scopolamine butylbromide exerts a dose-dependent antagonistic effect on Carbachol-induced gastrointestinal smooth muscle spasm. Scopolamine butylbromide can be used for the research of abdominal colic and pain associated with gastrointestinal spasm, functional abdominal pain, chronic gastropathy and gastric ulcer.

Application

Products | Products > Disease Areas > CNS Infection | Products > Disease Areas > Gastric Disease | Products > Disease Areas > Peptic Ulcer Disease | Products > Disease Areas > Muscle Disease | Products > Disease Areas > Pain | Products > Disease Areas > Experimental Autoimmune Encephalomyelitis | Products > Disease Areas > Gastric Ulcer | Products > Disease Areas > Muscle Relaxation and Spasm | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > mAChR

Product Information

• Catalog No.: HY-N0340
• CAS No.: 149-64-4
• Molecular Formula: C21H30BrNO4
• Molecular Weight: 440.37
• Purity: 99.04%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.25 mg/mL (5.11 mM); Clear solution
• Availability: In-stock

Source

Original product source